Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
21.6M
-
Shares change
-
+3.2M
-
Total reported value, excl. options
-
$988M
-
Value change
-
+$116M
-
Number of buys
-
67
-
Number of sells
-
-47
-
Price
-
$45.74
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q1 2021
131 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q1 2021.
Pulmonx Corp - COMMON STOCK (LUNG) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.6M shares
of 40.4M outstanding shares and own 53.51% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (1.19M shares), VANGUARD GROUP INC (1.14M shares), RTW INVESTMENTS, LP (1.13M shares), Capital World Investors (1.06M shares), GILDER GAGNON HOWE & CO LLC (1.05M shares), KPCB XIII Associates, LLC (995K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (937K shares), BlackRock Inc. (917K shares), ABG Innovation Capital Partners III GP Ltd (833K shares), and ABG-WTT Global Life Science Capital Partners GP Ltd (815K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.